NCT05670847View on ClinicalTrials.gov

Exogenous Ketone Esters for Drug Resistant Epilepsy

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 10, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

July 1, 2025

Conditions
Drug Resistant Epilepsy
Interventions
DRUG

Exogenous ketone ester

500 mg/kg orally three times daily (with at least 4 hours between each dose) for 28 days

Trial Locations (1)

82524

RECRUITING

Department of Pediatrics at Sohag University Hospital, Sohag

All Listed Sponsors
lead

Sohag University

OTHER